Search Results
Feb 05, 2026, 21:38 ET Singapore Biennale 2025: Trải nghiệm Singapore theo một cách hoàn toàn mới qua nghệ thuật
multimedia:https://www.prnewswire.com/vn/news-releases/u0073u0069u006Eu0067u0061u0070u006Fu0072u0065u002Du0062u0069u0065u006Eu006Eu0061u006Cu0065u002Du0032u0030u0032u0035u003Au002Du0074u0072u1EA3-302680913.htmlSOURCE
More news about: Singapore Biennale 2025 (SB2025)
Feb 05, 2026, 20:00 ET Vì sao các mô hình ngôn ngữ lớn đáng tin cậy sẽ định nghĩa kỷ nguyên tiếp theo của AI giai đoạn phát triển tiếp theo của AI
multimedia:https://www.prnewswire.com/vn/news-releases/u0076u0069u002Du0073u0061u006Fu002Du0063u0061u0063u002Du006Du006Fu002Du0068u0069u006Eu0068u002Du006Eu0067u006Fu006Eu002Du006Eu0067u1EEFu002D-302680151.htmlSOURCE
More news about: Appier
Feb 05, 2026, 19:36 ET Eisai und Henlius schließen exklusive Lizenzvereinbarung für den Anti-PD-1-Antikörper Serplulimab in Japan ab
heute den Abschluss einer exklusiven Vermarktungs- und Co-Exklusivlizenzvereinbarung für den Anti-PD-1-Antikörper Serplulimab (generischer Name, in der EU unter dem Markennamen Hetronifly® vertrieben) in Japan bekannt. Serplulimab ist ein neuartiger monoklonaler Anti-PD-1-Antikörper, der von Henlius
More news about: Henlius
Feb 05, 2026, 17:31 ET Primary Sclerosing Cholangitis Market Outlook Highlights Rising Demand and Expanding Treatment Landscape Throughout the Forecast Period (2025-2034) | DelveInsight
market share of individual therapies, and current and forecasted market size from 2020 to 2034, segmented into leading markets [the United States, the EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan].
More news about: DelveInsight Business Research, LLP
Feb 05, 2026, 16:15 ET Bank of America Announces Full Redemption of Its Series DD Preferred Stock and Related Depositary Shares
"Preferred Stock"), and the corresponding depositary shares each representing a 1/25th interest in a share of the Preferred Stock (CUSIP No. 060505EU4) (the "Depositary Shares").
More news about: Bank of America Corporation
Feb 05, 2026, 13:42 ET P&F Secures EU MDR CE Certification for TricValve® System
download multimedia:https://www.prnewswire.com/news-releases/pf-secures-eu-mdr-ce-certification-for-tricvalve-system-302680600.htmlSOURCE
More news about: P+F Products and Features
Feb 05, 2026, 12:35 ET Zenocutuzumab‑zbco Receives FDA Orphan Drug Designation for Treatment of Cholangiocarcinoma
the purpose of achieving superior outcomes for patients and their families. PTx's portfolio includes zenocutuzumab-zbco (BIZENGRI®) and sargramostim (EU: IMREPLYS®; US: LEUKINE®; and with Nobelpharma Co. Ltd for JAPAN: SARGMALIN®). Visit
More news about: Partner Therapeutics, Inc.
Feb 05, 2026, 12:13 ET Grand Copthorne Waterfront Hotel Singapore được vinh danh với giải thưởng ASEAN MICE Venue Award 2026
multimedia:https://www.prnewswire.com/vn/news-releases/u0067u0072u0061u006Eu0064u002Du0063u006Fu0070u0074u0068u006Fu0072u006Eu0065u002Du0077u0061u0074u0065u0072u0066u0072u006Fu006Eu0074u002Du0068-302680513.htmlSOURCE
More news about: Grand Copthorne Waterfront Hotel Singapore
Feb 05, 2026, 11:22 ET Optimizely Named a Leader in the 2026 Gartner® Magic Quadrant™ for Personalization Engines
optimizely.com.Optimizely, Optimizely One, and NetSpring are the trademarks of Optimizely North America Inc., and are registered (or registrations are pending) in the US, EU, UK and other countries. All third-party trademarks cited are the property of their respective owners and are used only for reference purposes.
More news about: Optimizely
Feb 05, 2026, 10:59 ET European Research and Innovation: the Politecnico di Milano Launches an Office in Brussels
future of EU programmesMILAN, Feb. 5, 2026 /PRNewswire/ -- The Politecnico di Milano has officially launched the Brussels Liaison Office, the University's new office dedicated to communication with EU institutions
More news about: Politecnico di Milano
Feb 05, 2026, 10:42 ET European Research and Innovation: the Politecnico di Milano Launches an Office in Brussels
future of EU programmesMILAN, Feb. 5, 2026 /PRNewswire/ -- The Politecnico di Milano has officially launched the Brussels Liaison Office, the University's new office dedicated to communication with EU institutions
More news about: Politecnico di Milano
Feb 05, 2026, 09:33 ET Bitpanda Joins Global Dollar Network, Bringing MiCA-Compliant USDG to European Markets
Robinhood, Worldpay and more.About USDG in the EUPaxos issues USDG in the EU through Paxos Issuance Europe OY ("PIE"). USDG is fully redeemable from Paxos on a one-to-one basis for U.S. dollars. All USDG token holders in the EU have a right of redemption against PIE at any time
More news about: Global Dollar Network
Feb 05, 2026, 09:00 ET The More than European Food and Drinks, Savoring Stories campaign expands its footprint in the United States as it wraps up its second year with a deeper understanding of European food culture among consumers and professionals
More EU culinary and wine connections engaging US consumers and tradeThe EU will further connect with consumers across the US through a series of B2C events this year. On the agenda: tastings, pairings, educational sessions, and immersive dining experiences. At the same time, the EU will engage
More news about: European Union
Feb 05, 2026, 09:00 ET Global Spirulina Market to Reach US$ 1,287.13 Million by 2032, Driven by Nutraceutical Demand, Sustainable Protein Adoption & Functional Food Growth
systems. On 2024, Cyanotech Corporation expanded its Spirulina Pacifica lineup with new gummies and enhanced production capacity. In October 2024, Parry Nutraceuticals regained the EU import licence for organic spirulina, while Algatech Ltd. unveiled a cleanlabel spirulina protein powder in September 2024, reshaping plantbased nutrition
More news about: MMR Statistics
Feb 05, 2026, 08:59 ET Connors Group Appoints Ian Prisuta as Chief Growth Officer to Expand Retail Strategy and Transformation Capabilities
tiered engagement and joint planning. He also led the modernization efforts across all U.S. retail brands while serving as a board member for one of the EU based portfolio companies.Previously, Prisuta served as a Senior Advisor at Boston Consulting Group (BCG), where he supported retail and
More news about: Connors Group
Feb 05, 2026, 08:37 ET Global Soluble Corn Fiber Market Set to Eclipse USD 78.6 Billion by 2036 as Functional Food Reformulation Hits Critical Mass | Future Market Insights'
https://www.futuremarketinsights.com/reports/corn-fiber-market Demand for Soluble Corn Fiber in EU: https://www.futuremarketinsights.com/reports/demand-for-soluble-corn-fiber-in-eu Insoluble Dietary Fiber Market -
More news about: Future Market Insights
Feb 05, 2026, 08:30 ET Responsible Data Return in Rare Disease Clinical Trials: What Sponsors Need to Know, Upcoming Webinar Hosted by Xtalks
Specialty Areas; and Victoria Watts, Vice President, Compliance Officer, for the live webinar on Thursday, February 26, 2026, at 11am EST (5pm CET/EU-Central).For more information, or to register for this event, visit
More news about: Xtalks
Feb 05, 2026, 08:00 ET Massimo Group Showcases MVR HVAC Pro Series at the GCSAA Conference, Accelerating Dealer, Fleet and International Expansion
include, among others, plans to accelerate dealer, fleet, and international expansion; expected demand and margins for the MVR HVAC Pro Series; preliminary EU exclusive distribution discussions; and references to long‑term growth and January 2026 dealer‑channel momentum. In some cases, forward-looking statements
More news about: Massimo Group
Feb 05, 2026, 07:49 ET Robin Zeng: Khai mở kỷ nguyên năng lượng bền vững bằng công nghệ không carbon
multimedia:https://www.prnewswire.com/vn/news-releases/u0072u006Fu0062u0069u006Eu002Du007Au0065u006Eu0067u003Au002Du006Bu0068u0061u0069u002Du006Du1EDFu002Du006Bu1EF7u002Du006Eu0067u0075u0079u0065-302680196.htmlSOURCE
More news about: Contemporary Amperex Technology Co., Limited (CATL)
Feb 05, 2026, 06:56 ET Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan
and co-exclusive development and manufacturing license agreement for the anti-PD-1 antibody serplulimab (generic name; marketed as Hetronifly® in the EU) in Japan. Serplulimab is a novel anti-PD-1 monoclonal antibody developed by Henlius and reported to have a unique binding mode distinct from existing
More news about: Henlius
Feb 05, 2026, 06:44 ET Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan
manufacturing license agreement for the anti-PD-1 antibody serplulimab (generic name, marketed as HANSIZHUANG in China and Hetronifly® in the EU) in Japan. Serplulimab, a novel anti-PD-1 monoclonal antibody developed by Henlius, is reported to possess a unique binding mode that differs from
More news about: Henlius
Feb 05, 2026, 05:53 ET 완전성 확보를 위한 업데이트 -- Office of the Chair of the International AI Safety Report
위험, 그리고 현재의 위험 관리 및 안전장치 현황에 대해 최신 정보를 반영한 국제 공동의 과학적 평가를 제공한다. 튜링상 수상자인 요슈아 벤지오(Yoshua Bengio)가 의장을 맡은 이번 두 번째 보고서는 100명 이상의 국제 전문가가 참여했으며, EU, OECD, UN을 포함한 30개국 이상의 국가 및 국제기구 추천 인사로 구성된 전문가 자문위원단의 지원을 받았다. 보고서의 주요 결과는 이달 말 인도가 주최하는
More news about: Office of the Chair of the International AI Safety Report
Feb 05, 2026, 05:12 ET AKTUALISIERUNG ZUR VOLLSTÄNDIGKEIT -- Office of the Chair of the International AI Safety Report
100 internationale Experten und wird von einem Expertenbeirat mit Nominierten aus mehr als 30 Ländern und internationalen Organisationen, darunter die EU, die OECD und die UNO, unterstützt. Die Ergebnisse des Berichts werden in die Diskussionen auf dem
More news about: Office of the Chair of the International AI Safety Report
Feb 05, 2026, 05:11 ET ASSA ABLOY Quarterly Report Q4 2025
on:08–505 100 31, +44 207 107 0613 or +1 631 570 5613This information is information that ASSA ABLOY AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08.00 CET on February
More news about: ASSA ABLOY
Feb 05, 2026, 05:08 ET ASSA ABLOY Quarterly Report Q4 2025
on:08–505 100 31, +44 207 107 0613 or +1 631 570 5613This information is information that ASSA ABLOY AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08.00 CET on February
More news about: ASSA ABLOY